Wednesday, April 29, 2026

Global AI Driven Rare Disease Diagnostics Firm 3Billion Enters the U.S. Insurance Market

3Billion is expanding globally, entering the U.S. insurance market, enhancing diagnostics, and pursuing drug development for growth.

North Korea Drone Incursions: Why South Korea’s Response is Raising Eyebrows

Jang Dong Hyuk criticizes President Lee's response to North Korea's drone incursion, calling it absurd and urging a special investigation into safety issues.

INNOSPACE Tests Satellite Rocket System as It Prepares for Brazilian Launch

INNOSPACE completes system integration test for the HANBIT-NANO rocket, preparing for its inaugural launch with international payloads.

Tag: Avtozma

Celltrion Launches New Autoimmune Drug Avtozma in Japan

Celltrion launches Avtozma for autoimmune diseases in Japan, expanding its product portfolio and strengthening market presence.

Top News

- Our Sponsors Ad -

Follow us